Highlights
KLSE: HARTA (5168)       HARTALEGA HOLDINGS BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
9.53   +0.06 (0.63%)  9.39 - 9.68  2,752,300
Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.

Financials


Market Cap: 32,665 Million

Market Cap 32,665 Million
NOSH 3,428 Million

Latest Audited Result:  31-Mar-2020

Latest Audited Result: 31-Mar-2020
Announcement Date 30-Jul-2020
Next Audited Result: 31-Mar-2021
Est. Ann. Date: 30-Jul-2021
Est. Ann. Due Date: 27-Sep-2021

Latest Quarter:  31-Mar-2021 [#4]

Latest Quarter: 31-Mar-2021 [#4]
Announcement Date 04-May-2021
Next Quarter: 30-Jun-2021
Est. Ann. Date: 04-Aug-2021
Est. Ann. Due Date: 29-Aug-2021
QoQ | YoY   11.73%  |    868.25%

Annual (Unaudited) ( EPS: 84.18, P/E: 11.32 )

Revenue | NP to SH 6,695,862  |  2,885,410
RPS | P/RPS 195.35 Cent  |  4.88
EPS | P/E | EY 84.18 Cent  |  11.32  |  8.83%
DPS | DY | Payout % 33.20 Cent  |  3.48%  |  39.44%
NAPS | P/NAPS 1.45  |  6.59
YoY   563.65%
NP Margin | ROE 43.36%  |  58.23%
F.Y. | Ann. Date 31-Mar-2021  |  04-May-2021

T4Q Result ( EPS: 84.18, P/E: 11.32 )

Revenue | NP to SH 6,695,862  |  2,885,410
RPS | P/RPS 195.35 Cent  |  4.88
EPS | P/E | EY 84.18 Cent  |  11.32  |  8.83%
DPS | DY | Payout % 33.15 Cent  |  3.48%  |  39.37%
NAPS | P/NAPS 1.45  |  6.59
QoQ | YoY   53.32%  |    563.65%
NP Margin | ROE 43.36%  |  58.23%
F.Y. | Ann. Date 31-Mar-2021  |  04-May-2021

Annualized Result ( EPS: 84.18, P/E: 11.32 )

Revenue | NP to SH 6,695,862  |  2,885,410
RPS | P/RPS 195.35 Cent  |  4.88
EPS | P/E | EY 84.18 Cent  |  11.32  |  8.83%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   22.52%  |    563.65%
NP Margin | ROE 43.36%  |  58.23%
F.Y. | Ann. Date 31-Mar-2021  |  04-May-2021


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Mar-2021 04-May-2021 31-Mar-2021 4 2,299,858 1,511,790 1,125,074 1,119,093 604,891 4,955,328 54.05% 48.92% 22.58% 3,417,468 67.30 67.10 32.75 32.65 17.70 17.65 1.4500 1.45   11.73%   868.25% 31-Mar-2021 8.93 13.27 27.27 6.16 3.67% 1.98% 04-May-2021 9.93 14.76 30.32 6.85 3.30% 1.78%
31-Mar-2021 25-Jan-2021 31-Dec-2020 3 2,129,901 1,345,873 1,007,827 1,001,640 329,785 4,169,311 32.92% 47.32% 24.02% 3,417,468 62.32 62.14 29.31 29.22 9.65 9.62 1.2200 1.22   83.80%   725.94% 31-Dec-2020 12.14 19.48 41.42 9.95 2.41% 0.79% 13.00 20.86 44.35 10.66 2.25% 0.74%
31-Mar-2021 27-Oct-2020 30-Sep-2020 2 1,346,016 682,961 549,698 544,958 130,261 3,349,579 23.90% 40.84% 16.27% 3,383,414 39.78 39.27 15.95 15.90 3.85 3.80 0.9900 0.98   148.02%   424.67% 30-Sep-2020 16.20 40.72 100.58 16.36 0.99% 0.24% 27-Oct-2020 18.28 45.95 113.49 18.46 0.88% 0.21%
31-Mar-2021 04-Aug-2020 30-Jun-2020 1 920,087 272,819 221,060 219,719 71,143 2,710,213 32.38% 24.03% 8.11% 3,387,767 27.16 26.84 6.49 6.41 2.10 2.08 0.8000 0.79   90.10%   133.59% 30-Jun-2020 13.00 47.87 200.44 16.25 0.50% 0.16% 04-Aug-2020 19.86 73.12 306.21 24.83 0.33% 0.11%
31-Mar-2020 18-May-2020 31-Mar-2020 4 777,898 137,575 115,711 115,579 68,996 2,524,266 59.70% 14.87% 4.58% 3,365,688 23.11 22.70 3.43 3.37 2.05 2.01 0.7500 0.74   -4.70%   26.51% 31-Mar-2020 6.88 29.77 200.35 9.17 0.50% 0.30% 9.13 39.50 265.87 12.17 0.38% 0.22%
31-Mar-2020 11-Feb-2020 31-Dec-2019 3 796,550 159,697 121,661 121,273 60,557 2,455,939 49.93% 15.27% 4.94% 3,364,301 23.68 23.24 3.60 3.54 1.80 1.77 0.7300 0.72   16.76%   1.27% 31-Dec-2019 5.48 23.15 152.02 7.51 0.66% 0.33% 11-Feb-2020 6.00 25.34 166.45 8.22 0.60% 0.30%
31-Mar-2020 05-Nov-2019 30-Sep-2019 2 709,424 137,327 104,206 103,867 60,421 2,349,722 58.17% 14.69% 4.42% 3,356,746 21.13 20.70 3.09 3.03 1.80 1.76 0.7000 0.69   10.42%   -13.60% 30-Sep-2019 5.25 24.84 169.67 7.50 0.59% 0.34% 05-Nov-2019 5.47 25.88 176.78 7.81 0.57% 0.33%
31-Mar-2020 06-Aug-2019 30-Jun-2019 1 640,101 121,654 94,254 94,063 63,651 2,311,569 67.67% 14.72% 4.07% 3,350,101 19.11 18.67 2.81 2.74 1.90 1.86 0.6900 0.67   2.96%   -24.67% 28-Jun-2019 5.24 27.42 186.63 7.59 0.54% 0.36% 06-Aug-2019 5.05 26.43 179.86 7.32 0.56% 0.38%
31-Mar-2019 07-May-2019 31-Mar-2019 4 683,889 113,680 91,414 91,360 63,195 2,228,470 69.17% 13.37% 4.10% 3,326,075 20.56 19.95 2.75 2.67 1.90 1.84 0.6700 0.65   -23.71%   -21.68% 29-Mar-2019 4.63 22.52 168.56 6.91 0.59% 0.41% 07-May-2019 5.05 24.56 183.85 7.54 0.54% 0.38%
31-Mar-2019 12-Feb-2019 31-Dec-2018 3 723,393 150,001 119,335 119,755 73,136 2,194,080 61.07% 16.50% 5.46% 3,324,364 21.76 21.10 3.60 3.49 2.20 2.13 0.6600 0.64   -0.38%   5.96% 31-Dec-2018 6.14 28.22 170.44 9.30 0.59% 0.36% 12-Feb-2019 5.45 25.05 151.29 8.26 0.66% 0.40%
31-Mar-2019 08-Nov-2018 30-Sep-2018 2 714,244 142,352 120,381 120,216 73,070 2,125,679 60.78% 16.85% 5.66% 3,321,375 21.50 20.84 3.62 3.51 2.20 2.13 0.6400 0.62   -3.73%   6.07% 28-Sep-2018 6.62 30.78 182.90 10.34 0.55% 0.33% 08-Nov-2018 6.31 29.34 174.34 9.86 0.57% 0.35%
31-Mar-2019 07-Aug-2018 30-Jun-2018 1 706,353 145,833 125,088 124,873 72,948 2,055,827 58.42% 17.71% 6.07% 3,315,851 21.30 20.61 3.77 3.64 2.20 2.13 0.6200 0.60   7.05%   29.56% 29-Jun-2018 5.99 28.12 159.06 9.66 0.63% 0.37% 07-Aug-2018 6.17 28.96 163.84 9.95 0.61% 0.36%
31-Mar-2018 15-May-2018 31-Mar-2018 4 616,841 134,972 116,899 116,646 66,124 1,983,748 56.69% 18.95% 5.88% 3,306,247 18.66 18.00 3.53 3.40 2.00 1.93 0.6000 0.58   3.21%   30.44% 30-Mar-2018 6.05 32.43 171.48 10.08 0.58% 0.33% 15-May-2018 6.00 32.16 170.07 10.00 0.59% 0.33%
31-Mar-2018 06-Feb-2018 31-Dec-2017 3 603,139 138,857 113,123 113,023 65,991 1,930,255 58.39% 18.76% 5.86% 1,649,791 36.56 17.60 6.85 3.30 4.00 1.93 1.1700 0.56   -0.28%   70.66% 29-Dec-2017 10.68 29.21 155.90 9.13 0.64% 0.37% 06-Feb-2018 10.84 29.65 158.23 9.26 0.63% 0.37%
31-Mar-2018 28-Dec-2017 30-Sep-2017 2 584,617 137,245 113,738 113,340 57,505 1,849,699 50.74% 19.46% 6.13% 1,643,009 35.58 17.06 6.87 3.31 3.50 1.68 1.1258 0.54   17.59%   59.15% 29-Sep-2017 6.96 19.56 100.89 6.18 0.99% 0.50% 28-Dec-2017 10.82 30.41 156.85 9.61 0.64% 0.32%
31-Mar-2018 08-Aug-2017 30-Jun-2017 1 601,041 115,736 96,429 96,386 41,121 1,757,877 42.66% 16.04% 5.48% 1,644,875 36.54 17.54 5.86 2.81 2.50 1.20 1.0687 0.51   7.78%   71.58% 30-Jun-2017 7.38 20.20 125.94 6.91 0.79% 0.34% 08-Aug-2017 7.15 19.57 122.02 6.69 0.82% 0.35%
31-Mar-2017 09-May-2017 31-Mar-2017 4 526,997 118,505 89,439 89,427 32,817 1,680,079 36.70% 16.97% 5.32% 1,640,862 32.12 15.38 5.45 2.61 2.00 0.96 1.0239 0.49   35.03%   45.29% 31-Mar-2017 4.96 15.44 91.01 4.84 1.10% 0.40% 09-May-2017 5.39 16.78 98.90 5.26 1.01% 0.37%
31-Mar-2017 14-Feb-2017 31-Dec-2016 3 456,287 78,327 66,400 66,226 32,866 1,617,360 49.63% 14.55% 4.09% 1,643,324 27.77 13.31 4.03 1.93 2.00 0.96 0.9842 0.47   -7.01%   -9.01% 30-Dec-2016 4.83 17.40 119.85 4.91 0.83% 0.41% 14-Feb-2017 4.75 17.11 117.87 4.83 0.85% 0.42%
31-Mar-2017 08-Nov-2016 30-Sep-2016 2 436,975 83,759 71,177 71,215 32,817 1,575,262 46.08% 16.29% 4.52% 1,640,898 26.63 12.75 4.34 2.08 2.00 0.96 0.9600 0.46   26.77%   17.88% 30-Sep-2016 4.64 17.42 106.91 4.83 0.94% 0.43% 08-Nov-2016 4.78 17.95 110.14 4.98 0.91% 0.42%
31-Mar-2017 02-Aug-2016 30-Jun-2016 1 401,827 68,129 56,398 56,176 32,851 1,531,863 58.48% 14.04% 3.67% 1,642,573 24.46 11.72 3.42 1.64 2.00 0.96 0.9326 0.45   -8.73%   -10.38% 30-Jun-2016 4.33 17.70 126.61 4.64 0.79% 0.46% 02-Aug-2016 4.24 17.33 123.98 4.55 0.81% 0.47%
31-Mar-2016 03-May-2016 31-Mar-2016 4 400,454 70,712 61,531 61,550 32,828 1,502,218 53.34% 15.37% 4.10% 1,641,409 24.40 11.68 3.75 1.80 2.00 0.96 0.9152 0.44   -15.44%   11.97% 31-Mar-2016 4.85 19.88 129.34 5.30 0.77% 0.41% 03-May-2016 4.14 16.97 110.41 4.52 0.91% 0.48%
31-Mar-2016 16-Feb-2016 31-Dec-2015 3 398,023 91,173 72,886 72,786 32,786 146,506,417 45.05% 18.31% 0.05% 1,639,324 24.28 11.61 4.44 2.12 2.00 0.96 89.3700 42.74   20.48%   46.99% 31-Dec-2015 5.94 24.46 133.78 0.07 0.75% 0.34% 16-Feb-2016 4.98 20.51 112.16 0.06 0.89% 0.40%
31-Mar-2016 05-Nov-2015 30-Sep-2015 2 379,345 75,069 60,553 60,411 32,743 141,761,197 54.20% 15.96% 0.04% 1,637,154 23.17 11.07 3.69 1.76 2.00 0.96 86.5900 41.36   -3.62%   25.44% 30-Sep-2015 4.85 20.93 131.44 0.06 0.76% 0.41% 05-Nov-2015 5.22 22.53 141.46 0.06 0.71% 0.38%
31-Mar-2016 04-Aug-2015 30-Jun-2015 1 320,515 79,924 62,790 62,681 32,774 1,386,601 52.29% 19.59% 4.52% 819,359 39.12 9.35 7.65 1.83 4.00 0.96 1.6923 0.40   14.03%   9.80% 30-Jun-2015 8.51 21.75 111.24 5.03 0.90% 0.47% 04-Aug-2015 8.60 21.98 112.42 5.08 0.89% 0.47%
31-Mar-2015 05-May-2015 31-Mar-2015 4 305,110 67,331 55,008 54,969 11,655 777,015 21.20% 18.03% 7.07% 777,015 39.27 8.90 3.53 1.60 1.50 0.34 1.0000 0.23   11.01%   11.82% 31-Mar-2015 8.67 22.08 122.55 8.67 0.82% 0.17% 05-May-2015 8.22 20.93 116.19 8.22 0.86% 0.18%
31-Mar-2015 10-Feb-2015 31-Dec-2014 3 286,414 68,997 49,644 49,517 23,247 1,172,134 46.95% 17.33% 4.22% 774,913 36.96 8.36 6.39 1.44 3.00 0.68 1.5126 0.34   2.82%   -14.44% 31-Dec-2014 7.03 19.02 110.02 4.65 0.91% 0.43% 10-Feb-2015 7.55 20.43 118.15 4.99 0.85% 0.40%
31-Mar-2015 18-Nov-2014 30-Sep-2014 2 275,238 64,902 48,314 48,160 23,079 1,109,141 47.92% 17.55% 4.34% 769,329 35.78 8.03 6.26 1.41 3.00 0.67 1.4417 0.32   -15.64%   -23.89% 30-Sep-2014 7.08 19.79 113.10 4.91 0.88% 0.42% 18-Nov-2014 6.80 19.01 108.63 4.72 0.92% 0.44%
31-Mar-2015 05-Aug-2014 30-Jun-2014 1 279,198 75,651 57,241 57,087 30,244 1,014,409 52.98% 20.50% 5.63% 756,119 36.93 8.15 7.55 1.67 4.00 0.88 1.3416 0.30   16.13%   -9.26% 30-Jun-2014 6.21 16.82 82.25 4.63 1.22% 0.64% 05-Aug-2014 6.72 18.20 89.01 5.01 1.12% 0.60%
31-Mar-2014 06-May-2014 31-Mar-2014 4 280,373 70,272 49,395 49,157 25,950 942,361 52.79% 17.62% 5.22% 741,432 37.82 8.18 6.63 1.43 3.50 0.76 1.2710 0.27   -15.06%   -21.09% 31-Mar-2014 6.85 18.11 103.32 5.39 0.97% 0.51% 06-May-2014 6.02 15.92 90.80 4.74 1.10% 0.58%
31-Mar-2014 11-Feb-2014 31-Dec-2013 3 267,820 74,673 57,989 57,876 25,936 913,344 44.81% 21.65% 6.34% 741,049 36.14 7.81 7.81 1.69 3.50 0.76 1.2325 0.27   -8.53%   -4.38% 31-Dec-2013 7.23 20.01 92.57 5.87 1.08% 0.48% 11-Feb-2014 7.01 19.40 89.76 5.69 1.11% 0.50%
31-Mar-2014 12-Nov-2013 30-Sep-2013 2 280,953 82,300 63,326 63,273 25,901 872,575 40.94% 22.54% 7.25% 740,035 37.96 8.20 8.55 1.85 3.50 0.76 1.1791 0.25   0.57%   7.98% 30-Sep-2013 7.48 19.70 87.49 6.34 1.14% 0.47% 12-Nov-2013 7.55 19.89 88.30 6.40 1.13% 0.46%
31-Mar-2014 06-Aug-2013 30-Jun-2013 1 278,014 81,917 63,015 62,912 29,398 806,758 46.73% 22.67% 7.80% 734,953 37.83 8.11 8.56 1.84 4.00 0.86 1.0977 0.24   0.99%   17.91% 28-Jun-2013 6.40 16.92 74.77 5.83 1.34% 0.62% 06-Aug-2013 6.79 17.95 79.32 6.19 1.26% 0.59%
31-Mar-2013 07-May-2013 31-Mar-2013 4 269,772 81,318 62,422 62,293 25,589 765,355 41.08% 23.14% 8.14% 731,138 36.90 7.87 8.52 1.82 3.50 0.75 1.0468 0.22   2.91%   24.56% 29-Mar-2013 4.94 13.39 57.98 4.72 1.72% 0.71% 07-May-2013 5.45 14.77 63.97 5.21 1.56% 0.64%
31-Mar-2013 05-Feb-2013 31-Dec-2012 3 259,565 78,368 60,621 60,529 25,585 726,055 42.27% 23.35% 8.34% 731,026 35.51 7.57 8.28 1.77 3.50 0.75 0.9932 0.21   3.30%   19.38% 31-Dec-2012 4.75 13.38 57.37 4.78 1.74% 0.74% 05-Feb-2013 4.65 13.10 56.16 4.68 1.78% 0.75%
31-Mar-2013 06-Nov-2012 30-Sep-2012 2 255,019 76,282 58,575 58,597 25,604 689,630 43.70% 22.97% 8.50% 731,548 34.86 7.44 8.01 1.71 3.50 0.75 0.9427 0.20   9.82%   27.03% 28-Sep-2012 4.40 12.62 54.93 4.67 1.82% 0.80% 06-Nov-2012 4.89 14.03 61.05 5.19 1.64% 0.72%
31-Mar-2013 07-Aug-2012 30-Jun-2012 1 247,678 69,914 53,435 53,358 - 654,183 - % 21.57% 8.16% 730,931 33.89 7.23 7.30 1.56 0.00 0.00 0.8950 0.19   6.69%   -2.59% 29-Jun-2012 4.02 11.86 55.07 4.49 1.82% 0.00% 07-Aug-2012 4.50 13.28 61.64 5.03 1.62% 0.00%
31-Mar-2012 09-May-2012 31-Mar-2012 4 240,217 64,460 50,066 50,012 21,855 619,922 43.70% 20.84% 8.07% 364,253 65.95 7.01 13.73 1.46 6.00 0.64 1.7019 0.18   -1.36%   -4.55% 30-Mar-2012 6.62 10.04 48.22 3.89 2.07% 0.91% 09-May-2012 6.51 9.87 47.41 3.83 2.11% 0.92%
31-Mar-2012 22-Feb-2012 31-Dec-2011 3 241,951 63,902 50,663 50,703 21,839 587,179 43.07% 20.94% 8.64% 363,984 66.47 7.06 13.93 1.48 6.00 0.64 1.6132 0.17   9.92%   3.05% 30-Dec-2011 4.87 7.33 34.96 3.02 2.86% 1.23% 22-Feb-2012 6.64 9.99 47.67 4.12 2.10% 0.90%
31-Mar-2012 08-Nov-2011 30-Sep-2011 2 229,542 59,551 46,171 46,127 21,826 555,088 47.32% 20.11% 8.31% 363,777 63.10 6.70 12.68 1.35 6.00 0.64 1.5259 0.16   -15.79%   -2.06% 30-Sep-2011 4.58 7.26 36.12 3.00 2.77% 1.31% 08-Nov-2011 4.55 7.21 35.88 2.98 2.79% 1.32%
31-Mar-2012 09-Aug-2011 30-Jun-2011 1 219,371 70,670 54,746 54,774 - 529,045 - % 24.96% 10.35% 363,705 60.32 6.40 15.06 1.60 0.00 0.00 1.4546 0.15   4.53%   32.11% 30-Jun-2011 4.65 7.71 30.88 3.20 3.24% 0.00% 09-Aug-2011 4.49 7.44 29.81 3.09 3.35% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  9 people like this.
 
Intrinsic99 Nazir Razak: Why no supertaxes on glove companies?

https://www.theedgemarkets.com/article/nazir-razak-why-no-supertaxes-glove-companies


read carefully what former banker tell you
06/05/2021 8:32 PM
Zrenxy https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1?

Decide yourselves ...see world need gloves or not ^^, Top 4 if all stop glove production....ASP wll hike 100% haha
06/05/2021 8:38 PM
Pgraduate123 My big toe asking why no tax on Cimb or musang king profit.
Read carefully what I just said
06/05/2021 8:43 PM
Wt6669 wake up la govern should support glove industrial bring this advantage to help malaysia and have the right to speak in world
07/05/2021 9:42 AM
bigfu 6/5/2021 short selling trades current 10 days
Total Net Short Position .
Topglove 249,570,092 shares 3.05%
Hartalega 50,292,243 shares 1.47%
Supermax 47,268,758 shares 1.74%
Kossan 30,785,337 shares 1.21%
07/05/2021 1:19 PM
shearer202 Dont be greedy ! Faster take your profits while it s still green ! Supermx will waterfalling this afternoon n drag all glove countets down to pre covid level !! Becareful all my friends !
07/05/2021 2:02 PM
sheldon Dead cat bounce happening now
07/05/2021 2:38 PM
pjseow Harta has a 60 % dividend policy . The amount of dividend is based on previous qtr eps. For example the last 9.5 sen was derived from
15.95 sen x 0.6 = 9.5 sen. The coming dividend of 17.7 s is from 29.31 x 0.6 = 17.7 s . The next QR dividend.should be 32.75 x 0.6 = 19.7 sen.
07/05/2021 3:28 PM
shearer202 Wow last minute pop up aftet the latest covid cases updated !
07/05/2021 5:04 PM
notailcatt0 buy some at low i think is fair price now
07/05/2021 5:11 PM
Mabel Hartalega no need to visit so often

Let them run the business themselves

That's what they are paid for..

Just come and revisit every quarter

Hartalega is my 1st love.. she's been good so far..

Meow
08/05/2021 6:29 AM
Mabel This is one the stock that you can just buy and forget..

If you are an investor no need to see the screen everyday..

Problem with most young Amoi, they want to be a short term trader.. They think they can beat the market..

Just go with the flow.. Ride the trend..

Right now Plantation is the best sector to be in..

Come and join Mabel to be a farmer. We have a job to feed 8 billion people across the planet..Right now we farmer are having a fantastic time... Dancing... Let's twist again...

Come back to Glove when they are ready to dance..

Hartalega will definitely fly when it matters

Meow Meow Meow Meow
08/05/2021 6:35 AM
yingkang87 Covid cases increase more today!! Monday good show!!
08/05/2021 7:49 PM
brian3381 Karma wil hit u. So hapy u
08/05/2021 8:36 PM
beso (日内瓦7日讯) 世界卫生组织(WHO)周五批准中国国有制药企业国药集团(Sinopharm)生产的新型冠状病毒疫苗用于紧急使用,这将推动中国在全球新冠疫苗接种方面发挥重要作用。  
该疫苗成为首个获得世卫组织支持的非西方国家研制的新冠疫苗,是中国在施打的两种主要疫苗之一,目前已累计为国内外数亿人接种。
这也是世界卫生组织首次批准中国疫苗用于传染病的紧急使用。

这个消息肯定会引发手套股大波动,看跌。lol
08/05/2021 9:30 PM
Mabel When Mabel was small when the Xmas Trees were tall, Mabel love watching Dallas with Daddy. Now Mabel feel like a part of the Erwing Family with her O&G Collections

https://www.youtube.com/watch?v=8sKX3tWaOew

The Erwing also loves big ranches and automation. That’s why Mabel also love the Plantation and Technology Stocks.

Our mission is to feed more than 8 billion people in more than 200 countries. Latest news is India and China are buying our Palm Oil with vengeance

Dr Mabel Mrwing - always use gloves one

No problem to touch Dick's 4 Personal Target..

Meow
09/05/2021 8:38 AM
Keyman188 U.S. Infections Ease; U.K. Deaths Slow to Two: Virus Update

(Bloomberg News / May 10, 2021, 7:07 AM GMT+8)


U.S. deaths from Covid-19 have been undercounted, President Joe Biden’s top medical adviser said, with the nationwide toll approaching 582,000. New cases in the U.S. dropped over the past week to the slowest pace since the end of September. Hospitalizations dipped to a seven-month low.

With more than a third of its adult population now fully vaccinated, the U.K. reported just two virus deaths on Sunday. The European Union hasn’t renewed its order for the AstraZeneca Plc vaccine beyond June.


## https://www.bloomberg.com/news/articles/2021-05-09/u-s-infections-ease-u-k-deaths-slow-to-two-virus-update?srnd=premium-asia
10/05/2021 7:47 AM
Keyman188 Great...Great improvement...
10/05/2021 7:48 AM
brian3381 Usa uk israel cases sharp drop. Gg gloves
10/05/2021 7:52 AM
Keyman188 WHO gives emergency approval to Sinopharm, first Chinese COVID-19 vaccine

07 May 2021 11:34PM (Updated: 08 May 2021 12:11AM)

GENEVA: The World Health Organization announced on Friday (May 7) it had approved a COVID-19 vaccine from China's state-owned drugmaker Sinopharm for emergency use.

The vaccine, one of two main Chinese shots that collectively have already been given to hundreds of millions of people in China and abroad, becomes the first COVID-19 shot developed by a non-Western country to win the WHO's backing.

It is also the first time the WHO has given emergency use approval to any Chinese vaccine for any infectious disease.

A WHO emergency listing is a signal to national regulators on a product's safety and efficacy, and would allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries.

"This afternoon, WHO gave emergency use listing to Sinopharm Beijing's COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality," the UN health agency's director-general Tedros Adhanom Ghebreyesus told a news conference.

Tedros also said that a separate expert panel has recommended two doses of Sinopharm vaccine for those aged 18 and above.

The WHO has previously given emergency approval to COVID-19 vaccines developed by Pfizer-BioNTech, AstraZeneca, Johnson & Johnson, and, last week, Moderna.

The decision to approve Sinopharm's vaccine was taken by WHO's technical advisory group, which began meeting on Apr 26 to review the latest clinical data as well as Sinopharm's manufacturing practices.

A separate group of WHO experts, the Strategic Advisory Group of Experts (SAGE), voiced concern this week over data provided by Sinopharm on the risk of serious side-effects in some patients, but was confident in the vaccine's ability to prevent disease, according to a document reviewed by Reuters.

SAGE found an efficacy of 78.1 per cent after two doses in multi-country Phase III clinical trials, according to the document. The vaccine's developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group, had announced an efficacy of 79.34 per cent.

The WHO has said it could reach a decision on China's other main COVID-19 vaccine, made by Sinovac Biotech, as soon as next week. The technical experts reviewed it on Wednesday.

China has deployed around 65 million doses of the Sinopharm vaccine and more than 200 million doses of the Sinovac shot. Both have been exported to many countries, particularly in Latin America, Asia and Africa, many of which have had difficulty securing supplies of vaccines developed in the West.


## https://www.channelnewsasia.com/news/asia/covid-19-sinopharm-who-emergency-approval-first-china-vaccine-14764686
10/05/2021 8:29 AM
Keyman188 Finally...finally mass production to worldwide...

CHEERS...
10/05/2021 8:29 AM
Keyman188 China-produced vaccines await approval by EU and WHO, will be 'major boon to the world'

The European Medicines Agency (EMA) has started a rolling review of China's Sinovac COVID-19 vaccine, the EU's top drug regulator announced Tuesday, and experts said that once the vaccine is approved, China will further fulfill its international responsibilities as a major power and provide support to the international community in the pandemic fight.

Sinovac and another China-produced COVID-19 jab, Sinopharm, are also under WHO assessment for emergency use, and results are anticipated in a week.

The EMA said the decision on whether Sinovac can be marketed in Europe will be based on preliminary results from laboratory and clinical studies.

According to the EMA, a rolling review is to speed up the assessment of a promising medicine during a public health emergency, allowing data to be reviewed as they become available from ongoing studies. A specific timeframe for the review is not provided, but the EMA said the process should "take less time than normal."

Sources at Sinovac told the Global Times on Wednesday that since there are many COVID-19 vaccines awaiting EMA approval, the process is not expected to be completed soon. The previous four vaccines took two to three months to be approved after rolling reviews began.

The agency has ongoing rolling reviews of three other vaccines, Sputnik, CureVac and Novavax.

The EMA has previously approved four COVID-19 vaccines, developed by BioNTech and Pfizer, Moderna, AstraZeneca and Janssen. If approved, the Sinovac vaccine will be the first non-Western COVID-19 vaccine to receive marketing authorization in the EU.

In April, Sinopharm's COVID-19 vaccine received a Good Manufacturing Practice (GMP) certificate from Hungarian authorities, the first Chinese COVID-19 vaccine to receive such a certificate from an EU country and a step forward for Chinese vaccines to become a global public good.

Vaccine experts pointed out that the issuance greatly enhances the competitiveness of China-produced vaccines in Europe and the confidence of smaller European countries in Chinese vaccines given the uneven distribution of vaccines in Europe.

"With reference to this certificate, it is also more likely that the EMA will approve the Chinese vaccine market license more quickly," Tao Lina, a Shanghai-based vaccine expert told the Global Times on Wednesday.

Sinovac and Sinopharm are also under WHO assessment for emergency use, and the results are anticipated in early May.

Cont...


## https://www.globaltimes.cn/page/202105/1222712.shtml
10/05/2021 9:07 AM
Keyman188 Another China vaccine mass production soon...
10/05/2021 9:07 AM
Pgraduate123 Why no limit Down?
10/05/2021 4:05 PM
shearer202 Pfizer set up HQ in Spore !! Spore SporeSporeSporeSporeSporeSporeSporeSpore............................... ........why not Malaysia ????
10/05/2021 6:53 PM
shearer202 Banker changed tactic already , this time more mco more downtrend ! Better stay sideline n watch show first !
10/05/2021 8:44 PM
GloveBurnHand 6.5 coming soon
10/05/2021 10:03 PM
shearer202 Rm 5.xx is not a dream now because Pfizer will start production in Spore soon , next time getting vaccine or oral pil is just like go to 7-11 buy gardenia ! Still dont want cut loss will suffer later !
11/05/2021 8:35 AM
GloveBurnHand World covid cases 607,573
without india -320k
world covid cases is drop to 280k only

USA DROP TO 20k ++
This is what we can see Vaccine success.
Dow jones break new high 35.000

now is Recovery stock theme

5.5 coming soon
11/05/2021 8:45 AM
Bgt 9963 Good morning...!
11/05/2021 8:47 AM
shearer202 Together we witness the end of glove games in 2021 !
11/05/2021 8:56 AM
Mabel You sure or not?

Which chart are you looking at?

Meow
11/05/2021 8:12 PM
Mabel Here also got so many Amoi?

I thought only Top Glove and Supermax..

OIC...

Here also got so many Sugar Daddies and Sugar Sisters

Meow
11/05/2021 8:14 PM
looiting Useless counter
11/05/2021 8:43 PM
shearer202 Can not say harta useless , it depends on your entry price bro , around rm 5 u buy n it s useful bro !
11/05/2021 10:18 PM
BountyOfTheBourse shearer202 go back gambling with your gambling gang frends in dnex, genting & air asia la
11/05/2021 10:50 PM
BountyOfTheBourse Posted by shearer202 > May 11, 2021 6:50 PM | Report Abuse

If u can tahan it drop back to 18 sens just hold for 3 years ! If not better sell off for other people n move to other accounts!

*******

ha ha ha LOL LOL LOL

this is shearer202 outburst in dnex, his favourite judi house

he so angry when someone attack dnex there loh

but he every day can come attack all gloves no sweat at all la hor
11/05/2021 10:50 PM
IdleMoney66 Duit Raya...TQ Harta
12/05/2021 12:12 PM
shearer202 https://www.channelnewsasia.com/news/business/america-mask-makers-face-post-covid-19-pandemic-meltdown-14788982
12/05/2021 1:47 PM
Singapore88 Suggestions
12/05/2021 1:57 PM
shearer202 Good luck to u all ! Yes , i m a big liar ! Good bye !
13/05/2021 9:37 AM
Pgraduate123 Shearer left already.. Cuz he knows Monday glove mania 2.0 begins... Led by harta
13/05/2021 11:27 AM
stockraider ALWAYS REMEMBER TO HEDGE YOUR SUCCESSFULT BETS ON GLOVES, TECHNOLOGY AND VACCINE WITH COMING PALM OIL SURE PRICE SURGE MAH!

Peter Bevelin, in his wonderful book “All I Want To Know…” tells the story of Napoleon’s mother, Letizia. She couldn’t understand why Napoleon should take on the British since things were going so well. So, she sold all her French holdings and exchanged them for British pounds.

Why? She reasoned, if her son won, she should have a good life in the victorious nation. But if Napoleon lost, she would not be wiped out but still be ok since she had the pounds. She hedged against the possibility of facing a zero.

Letizia’s story is the perfect example of how to arrange our affairs in life to protect against the downside.

“Anything times zero is zero,” said Warren Buffett, “and I don’t care how good the record is in every other year if one year there’s a zero…Charlie and I have seen guys go broke or close to it because 99 of 100 of their decisions were good, but the 100th did them in. “

Buffett uttered these words in Berkshire’s 2007 annual meeting which was a year before the global financial crisis blew up investors’ money.

The benefit of looking at the downside or what can go wrong is efficiency, writes Bevelin in his book –

Take investments as an example – If you first eliminate what doesn’t work or what won’t achieve what you want, you don’t have to spend a lot of time and attention analyzing the company.

If there is a huge downside – for example, a catastrophe risk of the key factors that are needed for success aren’t there or any other disqualifying factors like no sustainable advantage, bad and untrustworthy management of something else – just say ‘no thank you.’

Howard Marks wrote this sometime in 1990 –

The best foundation for above-average long-term performance is the absence of disasters. There will always be cases and years in which, when all goes right, those who take on more risk will do better than we do. In the long run, however, I feel strongly that seeking relative performance which is just a little bit above average on a consistent basis – with protection against poor absolute results in tough times – will prove more effective than ‘swinging for the fences.

So, the important mantra of sensible investing is – If I avoid the losers, the winners will take care of themselves.
13/05/2021 4:06 PM
Keyman188 Fully vaccinated people don’t need to wear masks outside, Fauci says

PUBLISHED THU, MAY 13 202112:39 PM EDT

~ In its guidelines, the CDC says “fully vaccinated people no longer need to wear a mask outdoors, except in certain crowded settings and venues.”

~ “We got to make that transition ... if you are going into a completely crowded situation where people are essentially falling all over each other, then you wear a mask,” Fauci said.

~ A report by the New York Times cites experts that say the CDC number is misleading, and that the actual number of outdoor transmissions could actually be below 0.1%.


Americans need to start getting used to seeing people outside without masks as more and more people get vaccinated against Covid-19, White House chief medical advisor Dr. Anthony Fauci said Thursday.

Fauci reiterated new guidance from the Centers for Disease Control and Prevention that said fully vaccinated people didn’t need to wear masks in public, unless they were in a crowd.

“We got to make that transition,” Fauci said in an interview with CBS News after anchor Gayle King said people give her “the side-eye” when she takes her mask off outside, even though she’s fully vaccinated. “If you are vaccinated and you are outside, put aside your mask, you don’t have to wear it.”

There is debate among medical experts over how much outdoor transmission is driving cases.

“The top line result of all studies included in the systematic review said less than 10% of cases are transmitted outdoors,” CDC Director Dr. Rochelle Walensky said Tuesday at a Senate hearing.

Sen. Susan Collins, R-Maine, blasted Walensky during the hearing, saying the agency’s “conflicting, confusing guidelines ... undermined public confidence and contradicts the scientific guidance of many experts.”

A report by the New York Times cites epidemiologists that say the CDC number is misleading, and that the actual number of outdoor transmissions could actually be below 0.1%.

Reports of new Covid-19 cases continued to decline in the U.S., averaging of 36,700 new cases per day over the last week as of Wednesday, the lowest daily case average Sept. 14, data complied by John Hopkins University shows.


## https://www.cnbc.com/2021/05/13/fully-vaccinated-people-dont-need-to-wear-masks-outside-fauci-says-.html
14/05/2021 12:57 AM
Keyman188 So glove need to wear??...
14/05/2021 12:58 AM
lanpetzai People use more condoms more than gloves
14/05/2021 8:17 AM
Bgt 9963 Good morning...!
14/05/2021 8:47 AM
Mabel As humans, it’s difficult to practice patience because…

We associate doing more with better results.
We hate being bored.
We are exposed to A LOT of noise in social and financial media.
We don’t like seeing our losers, so we sell on no fundamental news.
We often position size poorly, so we always have to keep on trading around our position.
We focus too much on quarterly earnings.
The list goes on…

As you probably know, the best investors make the fewest decisions...

Meow
14/05/2021 9:59 PM
stockraider Correctloh...thats why very successful investors are more than humans, actually they are unique super human mah!

Posted by Mabel > May 14, 2021 9:57 PM | Report Abuse

As humans, it’s difficult to practice patience because…

We associate doing more with better results.
We hate being bored.
We are exposed to A LOT of noise in social and financial media.
We don’t like seeing our losers, so we sell on no fundamental news.
We often position size poorly, so we always have to keep on trading around our position.
We focus too much on quarterly earnings.
The list goes on…

As you probably know, the best investors make the fewest decisions...
14/05/2021 10:08 PM
looiting Lai liou, lai liou
15/05/2021 10:26 AM